GENMAB

Welcome to the Brand page for “GENMAB”, which is offered here for Monoclonal antibody therapeutic pharmaceuticals for use in the treatment of cancer, acquired immune deficiency syndrome (aids), and other infectious diseases, autoimmune diseases, and cardiovascular diseases;[ biochemicals, monoclonal antibodies for in vitro or scientific research regarding cancer, acquired immune deficiency syndrome (aids), and other infectious diseases, autoimmune diseases, and cardiovascular diseases ];.

Its status is currently believed to be active. Its class is unavailable. “GENMAB” is believed to be currently owned by “Genmab A/S”.

Owner:
GENMAB A/S
Owner Details
Description:
Monoclonal antibody therapeutic pharmaceuticals for use in the treatment of cancer, acquired immune deficiency syndrome (AIDS), and other infectious diseases, autoimmune diseases, and cardiovascular diseases;[ biochemicals, monoclonal antibodies for in vitro or scientific research regarding cancer, acquired immune deficiency syndrome (AIDS), and other infectious diseases, autoimmune diseases, and cardiovascular diseases ];
Categories: MONOCLONAL ANTIBODY THERAPEUTIC PHARMACEUTICALS